In addition to the mushroom-shaped polyps picked up in colonoscopies, there are also flat polyps in the colon that are far more difficult to detect visually.
GE Healthcare’s GE-137 is a targeted contrast agent that seeks out the cancer once it is injected by needle in the patient’s arm. Under a strong red light, the contrast agent changes the color of the light at the site of the cancer so it can be detected by a specially equipped camera.
Read the News Medical report on colon cancer detection.
Related Articles on Colon Cancer Detection:
Nearly One-Third of Target Population Unscreened for Colon Cancer
Study: 42% of Polyps Missed in Colonoscopies With Poor Bowel Preps
Study: New Biopsy Needle Accurately Diagnoses Cancers of GI Tract
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
